BUZZ-Cencora rises after lifting 2025 profit forecast

Reuters

Feb 05, 2025

** Shares of drug distributor Cencora COR.N rise 1.7% to $255.77

** Co raises fiscal 2025 profit forecast, driven by robust demand for expensive specialty medicines

** Expects 2025 adj. profit to range between $15.25 and $15.55 per share, up from previous view of $15.15 to $15.45

** Reports adj. Q1 profit of 3.73 per share, beating estimates of $3.50 per share - data compiled by LSEG

** Q1 sales in its U.S. healthcare solutions segment rose 13.6% to $74.0 billion

** "COR is off to a strong year stock-wise, but we see this quarter/guidance as another reason to see further upside on both estimates and multiple expansion," brokerage Leerink Partners says

** Stock rose 9.4% in 2024

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2509803842"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2509803842\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2509803842?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-05 23:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2509803842","market":"us","top_or_hot":-1,"title":"BUZZ-Cencora rises after lifting 2025 profit forecast","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Cencora rises after lifting 2025 profit forecast </title></head><body><p>** Shares of drug distributor Cencora <span>COR.N</span> rise 1.7% to $255.77 </p><p>** Co <span>raises</span> fiscal 2025 profit forecast, driven by robust demand for expensive specialty medicines</p><p>** Expects 2025 adj. profit to range between $15.25 and $15.55 per share, up from previous view of $15.15 to $15.45</p><p>** <span>Reports adj. Q1 </span>profit of 3.73 per share, beating estimates of $3.50 per share - data compiled by LSEG  </p><p>** Q1 sales in its U.S. healthcare solutions segment rose 13.6% to $74.0 billion</p><p>** \"COR is off to a strong year stock-wise, but we see this quarter/guidance as another reason to see further upside on both estimates and multiple expansion,\" brokerage Leerink Partners says</p><p>** Stock rose 9.4% in 2024 </p><p> (Reporting by Sneha S K)</p><p> ((Sneha.SK@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Cencora rises after lifting 2025 profit forecast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Cencora rises after lifting 2025 profit forecast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-05 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Cencora rises after lifting 2025 profit forecast </title></head><body><p>** Shares of drug distributor Cencora <span>COR.N</span> rise 1.7% to $255.77 </p><p>** Co <span>raises</span> fiscal 2025 profit forecast, driven by robust demand for expensive specialty medicines</p><p>** Expects 2025 adj. profit to range between $15.25 and $15.55 per share, up from previous view of $15.15 to $15.45</p><p>** <span>Reports adj. Q1 </span>profit of 3.73 per share, beating estimates of $3.50 per share - data compiled by LSEG  </p><p>** Q1 sales in its U.S. healthcare solutions segment rose 13.6% to $74.0 billion</p><p>** \"COR is off to a strong year stock-wise, but we see this quarter/guidance as another reason to see further upside on both estimates and multiple expansion,\" brokerage Leerink Partners says</p><p>** Stock rose 9.4% in 2024 </p><p> (Reporting by Sneha S K)</p><p> ((Sneha.SK@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1430594728.SGD","symbol_name":"Eastspring Investments - Global Low Volatility Equity AS SGD","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nL4N3OW1P3:1","article_id":"2509803842","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2509803842","pubTimestamp":1738768198,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Cencora rises after lifting 2025 profit forecast ** Shares of drug distributor Cencora COR.N rise 1.7% to $255.77 ** Co raises fiscal 2025 profit forecast, driven by robust demand for expensive specialty medicines** Expects 2025 adj. profit to range between $15.25 and $15.55 per share, up from previous view of $15.15 to $15.45** Reports adj. Q1 profit of 3.73 per share, beating estimates of $3.50 per share - data compiled by LSEG  ** Q1 sales in its U.S. healthcare solutions segment rose 13.6% to $74.0 billion** \"COR is off to a strong year stock-wise, but we see this quarter/guidance as another reason to see further upside on both estimates and multiple expansion,\" brokerage Leerink Partners says** Stock rose 9.4% in 2024   ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC","COR":"CENCORA","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","BK4588":"碎股","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1084165304.USD":"FIDELITY WORLD \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","BK4175":"保健护理产品经销商","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4084":"特种房地产投资信托","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","BK4529":"IDC概念"},"translate_title":"BUZZ-Cencora上调2025年利润预测后股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COR":0.9},"content_text":"BUZZ-Cencora rises after lifting 2025 profit forecast ** Shares of drug distributor Cencora COR.N rise 1.7% to $255.77 ** Co raises fiscal 2025 profit forecast, driven by robust demand for expensive specialty medicines** Expects 2025 adj. profit to range between $15.25 and $15.55 per share, up from previous view of $15.15 to $15.45** Reports adj. Q1 profit of 3.73 per share, beating estimates of $3.50 per share - data compiled by LSEG  ** Q1 sales in its U.S. healthcare solutions segment rose 13.6% to $74.0 billion** \"COR is off to a strong year stock-wise, but we see this quarter/guidance as another reason to see further upside on both estimates and multiple expansion,\" brokerage Leerink Partners says** Stock rose 9.4% in 2024  (Reporting by Sneha S K) ((Sneha.SK@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}